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Background: Dental implant placement is a widely used treatment that provides functional and es-
thetic resolution for patients suffering from tooth loss. However, the incidence of peri-implant diseases
has been rising recently. Periodontal diseases and peri-implant diseases share many similarities. Hence,
it is important to find out whether patients with aggressive periodontal disease possess a higher risk of
developing peri-implant diseases. The aim of this study is to study whether generalized aggressive peri-
odontitis (GAgP) has similar survival rates (SRs) and marginal bone loss (MBL) when compared with
patients with chronic periodontitis (CP) and/or healthy patients (HPs).
Methods: An electronic literature search was conducted by one reviewer (AM) in several databases
from 2000 to 2013, including MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and
Cochrane Oral Health Group Trials Register databases, for articles written in English up to November
2013. Human clinical trials, either prospective or retrospective, that compared implant SR and MBL in
patients with a history of GAgP versus those with CP or HPs were included.
Results: A total of six non-randomized prospective clinical trials met the inclusion criteria. The results
showed SRs of 83.3% to 100% (GAgP), 96.4% to 100% (CP), and 96.9% to 100% (HP) over a mean period
of 48.01 – 71.99 months, with an overall risk ratio of 0.96 (95% confidence interval [CI] = 0.91 to 1.01,
P = 0.14, GAgP versus HP) and 0.94 (95% CI = 0.87 to 1.01, P = 0.09, GAgP versus CP). However, when
the ‘‘failure rate’’ as studied outcome was examined, meta-analysis presented an overall risk ratio of 4.00
for the comparison between patients with AgP and HPs and an overall risk ratio of 3.97 when compared
with patients with CP. The MBL weighted mean difference for each subgroup was 0.15 mm (95% CI = 0.04
to 0.26, HP versus CP), -0.28 mm (95% CI = -0.36 to -0.19, HP versus GAgP), and -0.43 mm (95%
CI = -0.53 to -0.33, CP versus GAgP) over a mean period of 30 – 18 months.
Conclusions: Implant placement in patients with a history of GAgP might be considered a viable option
to restore oral function with survival outcomes similar to those found in both patients with CP and HPs.
However, the risk ratio for failure in patients with AgP is significantly higher when compared with HPs
(4.0) and those with CP (3.97). J Periodontol 2014;85:1398-1407.
KEY WORDS
Dental implantation, endosseous; evidence-based dentistry; meta-analysis; periodontal diseases;
periodontitis; review.
doi: 10.1902/jop.2014.140135
* Department of Periodontology and Oral Medicine, University of Michigan, Ann Arbor, MI.
† Department of Periodontology, University of Lisbon, Lisbon, Portugal.
Volume 85 • Number 10
1398
S
uccess in implant dentistry relies on the initial os-
seointegration and long-term stability.1 Patient
systemic factors and susceptibility to peri-
odontal diseases, implant macrodesign and micro-
design, and periodontal pathogenic bacteria, among
others, have all been shown to play a role in achieving
long-term implant stability.2 Consequently, many
clinical studies have aimed at analyzing the effect of
a history of previous periodontal disease on implant
treatment success.3-10 Although a higher incidence
of peri-implantitis and a lower implant survival rate
(SR) were reported in patients susceptible to peri-
odontitis,11,12 there is still disagreement on the level
of this relationship.13,14 As occurs in natural den-
tition, once the disease is established and pro-
gressing, it determines implant prognosis. In this
sense, it is important to mention that the preexist-
ing ecologic conditions of the oral cavity influence
biofilm formation on implants. It has been estab-
lished that residual pockets act as niches of in-
fection for dental implants15 and that putative
periodontal pathogens are present even 1 year after
periodontally affected teeth are extracted.16 Fur-
thermore, it also has been established that putative
periodontal pathogens increase with longer loading
time and that this increase is more accentuated in
patients with a history of periodontitis or peri-implant
infections.17
Whereas chronic periodontitis (CP), associated
with either local or systemic factors, is the most com-
mon form of the disease, aggressive periodontitis (AgP)
is less frequent (<1% of the population).18 However,
the presence of potential risks such as AgP may also
have an influence on implant success. Despite some
common histopathologic characteristics shared be-
tween chronic and aggressive forms19 and the dif-
ferent criteria and methods that were used to diagnose
and define AgP, three major characteristics were
used to define the aggressive disease: 1) clinically
healthy with the exception of periodontitis; 2) rapid
attachment loss (AL) and bone breakdown; and 3)
familial aggregation.20,21 It often occurs in younger
patients (<30 years of age), specifically the localized
form, but it may also affect older patients.22 Other
characteristics can also be used in the diagnosis of
the disease: 1) amounts of microbial deposits incon-
sistent with the severity of periodontal tissue break-
down; 2) elevated proportions of Aggregatibacter
actinomycetemcomitans and Porphyromonas gingivalis;
3) phagocyte abnormalities; 4) hyper-responsive
macrophage phenotype, including elevated levels
of prostaglandin E2 and interleukin (IL)-1b; and 5)
self-arresting progression of AL and bone loss.20-22
Polymorphisms in genes regulating the expression of
IL-1, IL-6, IL-10, tumor necrosis factor, E-selectins,
Fc-g receptor, cluster of differentiation 14, toll-like
receptors, caspase recruitment domain 15, vitamin D
receptor, lactoferrin, caldesmon, heat shock protein
70, and Stac protein23 and major histocompatibility
complexes A9 and B1524 were associated with
AgP. As a consequence of these polymorphisms, the
inflammatory profile is altered, including, but not
limited to, polymorphonuclear neutrophil (PMN)
transendothelial migration and signaling functions,25
reduced chemotactic response, and depression in
neutrophil phagocytosis and superoxide production.26
Assuming that each periodontal entity has a dis-
tinct progressive pattern and different bacteria as-
sociated with it, it is critical to note that the numerous
factors related to implant failure and the absence
of long-term studies in association with a history of
generalized AgP (GAgP) do not permit the drawing
of noticeable correlations with implant survival/
success. Nonetheless, it is necessary to treat and
control periodontal disease, regardless of its progres-
sion pattern and subtype, before implant therapy is
initiated to improve implant long-term treatment
success.12
Several studies3-8 aimed at analyzing the in-
fluence of a history of aggressive periodontal dis-
ease on implant treatment outcome in terms of SR
and marginal bone loss (MBL). Results from these
longitudinal studies suggest that patients with GAgP
experienced higher implant failure rates when com-
pared with patients with CP and healthy patients
(HP). However, there is still no consensus, which is
achievable by a well-designed systematic review that
clarifies the effect of previous history of GAgP on
implant treatment outcome. Henceforth, the present
study aims at assessing whether patients who suf-
fered from GAgP have a higher implant failure rate
and MBL in implant prostheses when compared with
patients with CP and/or HPs.
MATERIALS AND METHODS
Information Sources and Development of Focused
Question
An electronic literature search was conducted by
one reviewer (AM) in several databases, including
MEDLINE, EMBASE, Cochrane Central Register of
Controlled Trials, and Cochrane Oral Health Group
Trials Register databases, for articles written in English
from January 2000 through November 2013. The
following PICO (patient, intervention, comparison,
and outcome) question was aimed to be answered:
Do edentulous patients restored with implant-supported
prostheses have a higher or similar implant SR and/
or MBL among patients with a history of GAgP and/
or HPs and/or patients with CP? The reporting of these
meta-analyses adhered to the Preferred Reporting
Items for Systematic Review and Meta-Analyses
statement.27
J Periodontol • October 2014 Monje, Alcoforado, Padial-Molina, Suarez, Lin, Wang
1399
Screening Process
Combinations of controlled terms (MeSH and EMTREE)
and keywords were used whenever possible. The
search terms used for the search in PubMed were
as follows (in which [mh] represents the MeSH
terms, [tiab] represents title and/or abstract, [pt]
represents publication type, and [la] represents
language): (‘‘periodontitis’’[mh] OR ‘‘aggressive peri-
odontal disease’’[tiab] OR (‘‘dental implantation,
endosseous’’[mh] OR ‘‘dental implants’’[mh]) AND
(‘‘aggressive periodontitis’’[tiab] OR ‘‘aggressive
periodontitis’’[mh])) AND (generalized [tiab]) AND
English [la] NOT (letter [pt] OR comment [pt] OR editorial
[pt]) NOT (‘‘animals’’[mh] NOT ‘‘humans’’[mh]). For
the screening process in EMBASE, Cochrane Cen-
tral Register of Controlled Trials, and Cochrane Oral
Health Group Trials Register databases, the follow-
ing terms were used: ‘‘aggressive periodontal disease,’’
‘‘aggressive periodontitis’’ in combination with ‘‘dental
implants’’ or ‘‘endosseous implants.’’ Additionally, a
manual search of implant-related journals, including
Clinical Implant Dentistry and Related Research,
Journal of Oral and Maxillofacial Implants, Clinical
Oral Implants Research, Implant Dentistry, Journal of
Dental Research, Journal of Clinical Periodontology,
Journal of Periodontology, and The International
Journal of Periodontics & Restorative Dentistry, from
November 2012 through November 2013, was also
performed to ensure a thorough screening process.
References in the excluded articles were also checked
to find studies that fulfilled the inclusion criteria.
Eligibility Criteria
Articles were included in this meta-analysis if they
met the following inclusion criteria: prospective or
retrospective human clinical trials in which the
outcomes of the implant-supported prosthesis in
patients with a history of GAgP were studied and
compared with the results obtained by a second
and/or third group (HPs and/or patients with a
history of CP). Furthermore, the articles included
had to report the implant survival for ‡12 months
after loading. Accordingly, several factors were
extracted from the selected studies and analyzed
(if possible): 1) the number of implants included; 2)
implant design, length, and width; 3) location of the
implants; 4) MBL; 5) success rate; 6) age; 7) pa-
tient’s systemic conditions; 8) smoking; 9) bone
augmentation procedure before implant placement;
and 10) microorganisms present during the last
follow-up appointment. Conversely, case reports,
systematic reviews, animal studies, studies with
no control group, and those studies in which in-
formation was not clear enough or was inconsistent
were excluded from this meta-analysis. In addi-
tion, it is of paramount importance to note that
non-randomized clinical trials might be subjected
to a higher risk of bias.28 For that reason, the
Newcastle-Ottawa scale (NOS) was used to assess,
by two masked examiners (AM and MP-M), the
quality of such studies for a proper understanding
of non-randomized studies.29
Data Analyses
The primary outcome was SR, and MBL was the
secondary outcome. The risk ratio of SR was es-
timated using a computer program.‡ The contri-
bution of each article was weighed. Random-effects
meta-analyses of the selected studies were applied
to avoid any bias caused by methodologic differ-
ences among studies. Forest plots were produced to
graphically represent the difference in outcomes of
AgP and CP or AgP and HPs for all included studies
using implant as the analysis unit. P = 0.05 was
used as the level of significance. Heterogeneity was
assessed with x2 test and I2 test, which ranges from
0% to 100%, and lower values represent less het-
erogeneity. In addition, the funnel plot was used to
assess for the presence of publication bias. In ad-
dition, a regression of year on logit event rate was
performed to ascertain the effect of implant failure
rate in AgP versus the year of follow-up. Authors
did not explicitly state through the included articles
the definition for ‘‘implant failure.’’ However, ac-
cording to the accepted terminology in this matter,
‘‘failure’’ is considered when implant can no longer
be in function because of mobility. Accordingly, to
obtain ‘‘implant failure rates’’ and meta-analyses,
they were deducted to 100, and the corresponding
SR (percentage) was reported.
The weighted mean difference (WMD) and 95%
confidence interval (CI) of MBL were calculated be-
tween three subgroups: 1) HP versus CP; 2) HP versus
GAgP; and 3) CP versus GAgP. Bar charts were used
to present the results of comparisons.
RESULTS
Study Selection
The database search resulted in a total of 120 ar-
ticles, of which 68 potentially relevant articles were
selected after an evaluation of their titles and ab-
stracts. After the initial screening, 18 articles were
selected for additional evaluation of the full-text
version (for being directly related with the aim of
the present study). Of these, only six articles ful-
filled the inclusion criteria and were subsequently
analyzed in this meta-analysis (Fig. 1). Details of
all included studies3,4,6,30-32 are summarized in
Table 1. Reasons for exclusion were as follows: 1) case
reports (n = 7); 2) no control group (n = 1); and 3)
‡ Review Manager v.5.0, The Nordic Cochrane Centre, The Cochrane
Collaboration, Copenhagen, The Netherlands.
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systematic reviews (n = 2). References of the ex-
cluded articles have been included in supplemen-
tary Figure 1 (in online Journal of Periodontology).
In addition, two more studies were excluded because
of a lack of either clear data display or the data needed
for the analysis.10,33 Conversely, all the included
studies3,4,6,30-32 were comparative prospective con-
trolled trials assessing implant treatment outcome
in patients with GAgP compared with HPs and/or
those with CP. From one of the included studies,6
data at the 1-year follow-up evaluation was the only
available data comparable with the other group (CP)
and, therefore, the only data that could be extracted
and analyzed.
Study Quality
All the articles included in the present systematic
review are prospective human clinical trials evalu-
ating implant survival in patients with a history of
GAgP. The NOS was used to assess the quality of such
studies for a proper understanding of non-randomized
studies.29 It is important to state that five4,6,30-32 of
the six included articles were developed by the same
group (Department of Peri-
odontology, Dental School of
Medicine, Philipps University,
Marburg, Germany). This may
lead to some risk of bias at-
tributable to data overlapping.
In addition, some data were not
clear enough to be extracted
from these studies (i.e., standard
deviation of MBL or success rate).
Nonetheless, according to the
NOS, a mean score of 6.33 –
0.66 (33.3% [seven stars], 66.6%
[six stars]) was obtained, show-
ing the ‘‘medium-high’’ level of
evidence of the included studies.
Effect of GAgP on SR
The SR of the included studies
ranged from 83.3% to 100% for
the GAgP group, 96.4% to 100%
for the CP group, and 96.9% to
100% for the HP group. Meta-
analysis for the comparison of
SR among selected studies pre-
sented an overall risk ratio of
0.96 (95% CI = 0.91 to 1.01)
for the comparison between
AgP and HP with no significant
difference (P = 0.14) (Fig. 2).
For the comparison of SR be-
tween AgP and CP, an overall
risk ratio of 0.94 (95% CI = 0.87
to 1.01) with P = 0.09 was found
(Fig. 2). The comparisons presented a low (P value
for x2 test = 0.14 and I2 test = 14%) to moderate (P
value for x2 test = 0.09 and I2 test = 39%) hetero-
geneity among the pooled data, for the former and
latter comparisons, respectively.
However, when the event ‘‘failure rate’’ as studied
outcome was examined, meta-analysis presented
an overall risk ratio of 4.00 (95% CI = 1.79 to 8.93)
for the comparison among patients with AgP and HPs,
and a statistically significant difference (P <0.001)
was found (Fig. 3). For the comparison of failure rate
between patients with AgP and CP, an overall risk
ratio of 3.97 (95% CI = 1.68 to 9.37) and a statisti-
cally significant difference (P <0.001) were detected
(Fig. 3). The comparisons presented a low hetero-
geneity among the pooled data.
Effect of GAgP on MBL
Forest plots were used to show the heterogeneity
among the pooled data. Three separate bar charts
were subsequently generated to present the WMD
of each subgroup: HP versus CP, HP versus GAgP,
and CP versus GAgP. For HP versus CP, WMD was
Figure 1.
Flowchart of the screening process used for this systematic review. Records excluded (n = 50) did not meet
inclusion criteria.
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0.15 mm, with 95% CI = 0.04 to 0.26 mm, favor-
ing the CP group. For HP versus GAgP, WMD was
-0.28 mm, with 95% CI = -0.37 to -0.19 mm,
favoring the HP group. The WMD for each subgroup
was 0.15 mm (95% CI = 0.04 to 0.26, HP versus
CP, favoring CP), -0.28 mm (95% CI = -0.36 to
-0.19, HP versus GAgP, favoring HP), and -0.43
mm (95% CI = -0.53 to -0.33, CP versus GAgP,
favoring CP) (Fig. 4).
Effect of Follow-Up Period on SR of GAgP
The length of follow-up period was analyzed using
meta-regression. The results of regression analysis
showed that the length of follow-up period did not
significantly influence the outcome in either HP
versus GAgP (P = 0.72) or CP
versus GAgP (P = 0.94). Ad-
ditionally, as shown in Figure
5, no statistically significant
difference was found regarding
the regression of year on logit
event rate for implant failure
rate in GAgP (P = 0.38).
DISCUSSION
Implant survival is no longer
considered a challenge; how-
ever, in the pursuit of excel-
lence in implant dentistry,
longevity must be sought.
Many factors were shown to
influence the final outcome
in implant therapy. Among
others, patients with a previous
history of periodontal disease
and smokers may exhibit hi-
gher incidences of implant
failure and complications than
patients without such condi-
tions.34 Thus, the current sys-
tematic review aims to determine
the risk of the aggressive entity
of periodontal disease on im-
plant treatment outcome. It
was evidenced that, within the
limitations, when evaluating SR
as the event, patients with a
history of GAgP had similar SRs
when compared with the CP and
HP groups. Nonetheless, when
the ‘‘failure rate’’ event was ex-
amined, a risk ratio of 4.0 was
found compared with HPs and
3.97 when compared with pa-
tients with a history of CP.
However, because of the small
sample size of the ‘‘failed implants’’ group, it is not
possible to draw conclusive statements regarding the
risk ratio. Furthermore, results from this study must be
interpreted cautiously because of the limitations in
the studies included.
Many studies displayed the factors that may trigger
pathologic bone resorption,35,36 which can be caused
by either biomechanical37 or biologic/microbial fac-
tors.34 Apse et al.38 stated that the peri-implant sulcus
behaves similar to the periodontal sulcus, and, there-
fore, an inflammatory process similar to periodontitis
occurs around implants, i.e., peri-implantitis. This
fact was supported recently by Safii et al.,39 who
showed that higher MBL occurred in patients with a
history of periodontal disease than in periodontally
Figure 2.
Meta-analysis for the comparison of SR between patients with GAgP and HPs (A) and between patients
with GAgP and CP (B). IV = inverse model.
Figure 3.
Meta-analysis for the comparison of failure rate between patients with GAgP and HPs (A) and between
patients with GAgP and CP (B). IV = inverse model.
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healthy individuals. Nevertheless, the question remains
whether the peri-implantitis is the consequence of
a primary infectious process or, on the contrary,
whether the infection takes place after the tissue
breaks down. Recently, Rasperini et al.8 found that
MBL around implants was correlated with the initial
diagnosis of periodontitis and smoking history, in
agreement with previous studies.40-42 Consequently,
a higher MBL promotes better environment for bac-
terial colonization and resulted in a more rapid pro-
gression of peri-implantitis. Similarly, Mengel et al.4
showed that patients with GAgP exhibited MBL of 2.07
mm during the first year after implant placement and
3.37 mm at the end of the 10-year follow-up, and the
MBL is more statistically sig-
nificant than in HPs. De Boever
et al.3 demonstrated that MBL
is not only significantly higher
in patients with GAgP, but it
was also related to bleeding on
probing, age, inflammation,
presence of plaque, probing
depth, and smoking. In agree-
ment with these findings, the
present systematic review il-
lustrates that individuals with
a history of GAgP displayed
higher MBL when compared
with HPs or those with CP, but
it has to be interpreted cau-
tiously because the amount
is relatively small (0.28 to
0.43 mm) and might not have
clinical significance. In addi-
tion, it is interesting to mention
that, as shown by Cho-Yan Lee
et al.43 and validated recently
by a systematic review con-
ducted by Atieh et al.,44 a his-
tory of CP does not represent
a risk factor for peri-implantitis
as long as patients are enrol-
led in a maintenance program.
However, limitations of the
present study must be high-
lighted when interpreting the
present results to avoiding
misunderstanding. Most of the
included studies did not report
the standard deviation, so it was
not possible to analyze the data
obtained for MBL.
Investigations demonstrated
the transmission of putative
periodontal pathogens from
periodontally involved areas
to implant sites. Mombelli et al.45 identified the same
pathogens in peri-implant lesionsas theones thatwere
present 6 months before in natural dentition. In this
sense, De Boever and De Boever46 identified peri-
odontal pathogens in the peri-implant sulcus up to 6
months after implant placement in partially eden-
tulous individuals successfully treated for advanced
AgP. Regarding the bacterial composition in the peri-
implant mucosa, it was shown that an increase of
20% in the proportion of spirochetes and a decrease of
cocci from 61% up to 47.5% occurred in the de-
velopment of peri-implant disease.47 Mengel and
Flores-de-Jacoby30 showed a higher number of
motile rods at the end of the follow-up (3 years),
Figure 4.
Funnel plot to show the weighted mean of MBL for HP versus CP, HP versus GAgP, and CP versus GAgP.
Figure 5.
Regression of year on logit event rate for implant failure rate in GAgP.
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although this was not statistically significant com-
pared with HPs (7.82% versus 9.69%, respectively).
Interestingly, in the follow-up of these results on their
prospective study showing long-term results,4 the
difference between HPs and patients with GAgP be-
came statistically significant (cocci, 86.75%; non-
motile rods, 8.75%; motile rods, 1.5% versus cocci,
70.4%; non-motile rods, 13.78%; and motile rods, 6.58%,
respectively). As stated,48 a higher peri-implant bone
resorption promotes bacterial colonization and a more
rapid progression of peri-implantitis; hence, once the
initial lesion has taken place, the condition readily
worsens by increasing in number the percentage of
non-motile microorganisms. Nevertheless, for short- to
midterm, relative homogeneity of the microorganism
distribution was found. Henceforth, this finding
stresses the fact that the etiologic factor of this entity
(GAgP) does not depend on the putative pathogenic
bacteria but on the host susceptibility.
In addition to this suggestive evidence, it is im-
portant to emphasize that patients with GAgP are
susceptible for reasons beyond the presence of
particular pathogens.49 As mentioned above, there
are a number of factors, often unmodifiable, in pa-
tients with AgP that would potentially play a role in
implant success. These factors include the follow-
ing: 1) genetic polymorphisms23,24; 2) alterations of
the immune system (phagocyte abnormalities and
hyper-responsive macrophage phenotype,20-22 al-
tered PMN transendothelial migration and signaling
functions,25 reduced chemotactic response,50 and
depression in phagocytosis and superoxide pro-
duction)26; 3) depression, stress, and loneliness50;
4) oral hygiene; and 5) tobacco consumption. There
is much to learn from these studies that might be
applied to the study of peri-implantitis and its as-
sociation with factors influencing the presence of
AgP. Furthermore, the SR, success rate, and implant
prognosis in those cases remain to be determined.
Accordingly, large-scale case-control clinical trials
should be conducted.
CONCLUSIONS
The dearth of scientific evidence in this matter
does not allow for drawing clear conclusions.
However, within the limitations exhibited, it can be
concluded that implant placement in patients with
a history of GAgP might be considered a viable
option to restore oral function with survival out-
comes similar to those found in both HPs and
those with CP. Nonetheless, when the failure rate
event was examined, a risk ratio of 4.0 was found
compared with HPs and 3.97 when compared with
patients with a history of CP. Therefore, because
of the number of unmodifiable conditions that
might play a determinant role, both in AgP and
peri-implantitis processes, a comprehensive implant
maintenance program to identify peri-implant
bone loss early is highly encouraged, specifically
in patients with a history of generalized aggressive
periodontal disease. Moreover, larger and longer
follow-up studies and more standardized protocols
are needed to validate the current findings.
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